Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Minervo is a **topical multimodal analgesic lotion** being developed by Synergistic Therapeutics for **neuropathic pain**. Based on the provided source material, the formulation combines a **nonsteroidal anti-inflammatory drug** with an **N-methyl-D-aspartate receptor antagonist**, with the goal of delivering high skin penetration below the subcutaneous layer and producing local relief of neuropathic pain through combined anti-inflammatory and glutamatergic pathway modulation. The specific active ingredients and molecular targets beyond these broad pharmacologic components were not disclosed in the available company information.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Minervo.